Matthew W. Taylor

At its annual general meeting held on October 14, 2025, Matthew W. Taylor was elected as a new director.

Mr. Taylor brings to the Board an expertise in investment, product liability, and class action litigation and has achieved meaningful redress for investors, consumers, and survivors of institutional abuse. Mr. Taylor is committed to giving back to the community and is a supervising lawyer at the Osgoode Hall Law School Investor Protection Clinic. He can be reached at  416.572.7315.

Mr. Taylor applies a unique analytical perspective to his practice, and draws on his previous career as a protein biochemist involved in HIV and cancer research. This rigorous scientific training allows him to master complex technical evidence. He has experience in investor protection, professional liability, pharmaceutical & medical device product liability, and institutional abuse litigation and is also a frequent writer, speaker, and lecturer on securities litigation and class actions and writes a securities law column for Investment Executive.

Mr. Taylor practices at a leading plaintiff’s class action firm where his practice is devoted entirely to complex class action and multi-plaintiff litigation. He has been counsel on multiple trials, including a common issues trial and various motions, including summary judgment, certification pursuant to the Class Proceedings Act, and leave to proceed under Part XXIII.1 of the Securities Act. He has appeared before the Court of Appeal for Ontario, the Ontario Superior Court of Justice, and the Commercial List and sits on the executive of the class action section of the Ontario Bar Association and is Practice Group Leader for The Advocates’ Society Class Actions Practice Group.

CV

Doctor of Laws (JD), University of Toronto, 2019
MSc Laboratory Medicine & Pathobiology, University of Toronto, 2016
BSc Combined First Class Honours in Biochemistry & Molecular Biology and Microbiology & Immunology, Dalhousie University, 2013